ES2128051T3 - Isomero de doble enlace de la equilina, procedente de la isomerizacion acida de la equilina. - Google Patents

Isomero de doble enlace de la equilina, procedente de la isomerizacion acida de la equilina.

Info

Publication number
ES2128051T3
ES2128051T3 ES95915579T ES95915579T ES2128051T3 ES 2128051 T3 ES2128051 T3 ES 2128051T3 ES 95915579 T ES95915579 T ES 95915579T ES 95915579 T ES95915579 T ES 95915579T ES 2128051 T3 ES2128051 T3 ES 2128051T3
Authority
ES
Spain
Prior art keywords
equiline
isomer
double link
acid isomerization
isoestrone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95915579T
Other languages
English (en)
Inventor
Frederick Quincy Gemmill Jr
Chester Eugene Orzech
Steven Jay Adelman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Application granted granted Critical
Publication of ES2128051T3 publication Critical patent/ES2128051T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

ESTE INVENTO SE REFIERE A DL 9(11)-DEHIDRO-8-ISOESTRONE, DE FORMULA (VI), AL PROCEDIMIENTO PARA SU PREPARACION, A LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN DICHA {DL}9(11)DEHIDRO-8-ISOESTRONE (VI) Y AL EMPLEO DE DICHA {DL}9(11)-DEHIDRO8-ISOESTRONE (VI) PARA MODIFICAR EL EQUILIBRIO ENTRE LA PRODUCCION DE HUESO Y LA RESORCION DE HUESO, Y COMO UN ANTIOXIDANTE EN UN HUESPED ANIMAL, INCLUIDO EL HOMBRE.
ES95915579T 1994-04-08 1995-04-06 Isomero de doble enlace de la equilina, procedente de la isomerizacion acida de la equilina. Expired - Lifetime ES2128051T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/224,849 US5395831A (en) 1994-04-08 1994-04-08 Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone

Publications (1)

Publication Number Publication Date
ES2128051T3 true ES2128051T3 (es) 1999-05-01

Family

ID=22842497

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95915579T Expired - Lifetime ES2128051T3 (es) 1994-04-08 1995-04-06 Isomero de doble enlace de la equilina, procedente de la isomerizacion acida de la equilina.

Country Status (18)

Country Link
US (3) US5395831A (es)
EP (1) EP0754190B1 (es)
JP (1) JPH09511748A (es)
KR (1) KR970702291A (es)
CN (1) CN1149298A (es)
AT (1) ATE177111T1 (es)
AU (1) AU688029B2 (es)
CA (1) CA2186486A1 (es)
DE (1) DE69508068T2 (es)
DK (1) DK0754190T3 (es)
ES (1) ES2128051T3 (es)
GR (1) GR3030185T3 (es)
HU (1) HUT76338A (es)
IL (1) IL113178A (es)
NZ (1) NZ283951A (es)
TW (1) TW314468B (es)
WO (1) WO1995027724A1 (es)
ZA (1) ZA952771B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
WO1997008187A1 (en) * 1995-08-30 1997-03-06 Eli Lilly And Company N-butylsulfonate esters of estrogens
IL119468A (en) * 1995-11-06 2000-02-29 Akzo Nobel Nv Method of isomerisation of equilin or derivatives thereof
US5998639A (en) * 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
ID18256A (id) * 1996-09-16 1998-03-19 American Home Prod Penggunaan dari 8,9-dehidro estron sebagai estrogen dengan hasil netral pada tingkat prolaktin
IL124213A (en) * 1997-05-02 2004-12-15 Akzo Nobel Nv Sulfation of estrogen mixtures
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
US5866561A (en) * 1997-08-21 1999-02-02 Scimed Life Systems, Inc. Local delivery of estrogen for angiogenesis
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
ES2287184T3 (es) 2000-11-03 2007-12-16 Washington University Estructuras aromaticas modificadas con sustituyentes hidroxi-, que tienen actividad citoprotectora.
AU2002228891A1 (en) * 2000-11-17 2002-05-27 Washington University Cytoprotective estrogen derivatives
US20030158432A1 (en) * 2002-01-08 2003-08-21 Leonard Thomas W. Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
US6855735B2 (en) 2002-03-20 2005-02-15 Temple University Of The Commonwealth System Of Higher Education Ketamine treatment of restless legs syndrome
US7186707B2 (en) * 2002-04-01 2007-03-06 University Of Florida Prodrugs for use as ophthalmic agents
US7300926B2 (en) * 2002-04-01 2007-11-27 University Of Florida Research Foundation, Inc. Steroidal quinols and their use for estrogen replacement therapy
ATE353907T1 (de) * 2002-04-01 2007-03-15 Univ Florida Steroidische chinole als antioxidantien-vorstufen
US20070213310A1 (en) * 2002-04-01 2007-09-13 Laszlo Prokai Prodrugs for Use as Ophthalmic Agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE205169C (es) *
US3394153A (en) * 1965-08-18 1968-07-23 Merck & Co Inc Process for the preparation of d, 1-8-dehydroestrone, and intermediates obtained therefrom
US3391170A (en) * 1965-09-21 1968-07-02 Smith 13-alkylogona-1, 3, 5 (10), 9 (11)-tetraenes
US3385872A (en) * 1966-08-29 1968-05-28 Syntex Corp Process for the preparation of 3-hydroxy-19-nor-delta1, 3, 5(10), 9(11)-tetraene steroids
US3471528A (en) * 1968-02-21 1969-10-07 Lilly Co Eli Method for producing delta**9(11) unsaturation in estrone and related compound
US3542819A (en) * 1968-06-11 1970-11-24 American Home Prod Process for preparing 8-isoestrone
US3649621A (en) * 1969-12-19 1972-03-14 American Home Prod Novel 3-cyclopentyl ethers of 13-alkylgon-poly-enes
US3689512A (en) * 1970-10-06 1972-09-05 American Home Prod Novel 3-etherified-1,3,5(10)-triene-steroids and process thereof
DE3014120A1 (de) * 1980-04-12 1981-10-29 Hoechst Ag, 6000 Frankfurt Verfahren zur synthese von oestron bzw. oestronderivaten
DD205169A1 (de) * 1982-05-26 1983-12-21 Adw Ddr Verfahren zur herstellung von 9(11)-dehydro-oestra-1,3,5(10)-trienen
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone

Also Published As

Publication number Publication date
CA2186486A1 (en) 1995-10-19
ATE177111T1 (de) 1999-03-15
GR3030185T3 (en) 1999-08-31
US5395831A (en) 1995-03-07
EP0754190A1 (en) 1997-01-22
NZ283951A (en) 1998-07-28
DK0754190T3 (da) 1999-09-27
HUT76338A (en) 1997-08-28
JPH09511748A (ja) 1997-11-25
AU688029B2 (en) 1998-03-05
EP0754190B1 (en) 1999-03-03
HU9602755D0 (en) 1996-11-28
IL113178A (en) 2000-07-26
WO1995027724A1 (en) 1995-10-19
US5496814A (en) 1996-03-05
IL113178A0 (en) 1995-06-29
TW314468B (es) 1997-09-01
ZA952771B (en) 1996-10-04
DE69508068D1 (de) 1999-04-08
US5552395A (en) 1996-09-03
CN1149298A (zh) 1997-05-07
DE69508068T2 (de) 1999-10-28
KR970702291A (ko) 1997-05-13
AU2242195A (en) 1995-10-30

Similar Documents

Publication Publication Date Title
ES2128051T3 (es) Isomero de doble enlace de la equilina, procedente de la isomerizacion acida de la equilina.
RU94027577A (ru) Производные 1-бензолсульфонил-1,3-дигидро-2н-бензимидазол-2-она, способ их получения, содержащая их фармацевтическая композиция
PT94504A (pt) Processo para a preparacao de composicoes farmaceuticas aquosas em suspensao para ingredientes activos substancialmente insoluveis em agua
GB2210879B (en) 4h-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
BG104544A (en) Novel acylguanadine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
EP0911321A3 (en) Compounds for the treatment of osteoporosis
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
CA2234642A1 (en) 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
IL91753A0 (en) 7-substituted derivatives of 3,5-dihydroxyhept-6-ynoic acid,a process for the preparation thereof and pharmaceutical compositions containing them
MY115339A (en) Compositions containing micronized nebivolol
MX9700564A (es) Derivados de benzoilo y sintesis de los mismos.
AP9801269A0 (en) Prostaglandin agonists.
ATE238986T1 (de) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
DE69300453D1 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
IL112630A (en) Derivatives of (2-(ar)alkyldithioindane-2-carboxamido) tricyclic-oxobenzazepine and similar compouds useful as inhibitors of enkephalinase, their preparation and pharmaceutical compositions containing them
IL85425A (en) Anticonvulsant compositions containing substituted benzoyl anilides, some such novel compounds and process for their preparation
AP9801417A0 (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders.
HUP9903369A2 (hu) 8(9)-Dehidroösztradiol-származékok
IT1265045B1 (it) Composizione farmaceutica atta a inibire la sintesi della lipoproteina (a)
WO1997018238A3 (en) Crf analogs
UY23885A1 (es) Composiciones pesticidas que contienen derivados de acido fenilacetico y procedimiento para su preparacion

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 754190

Country of ref document: ES